{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:59:50Z","timestamp":1791082790580,"version":"4.1.0"},"reference-count":135,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cancer associated fibroblasts (CAF) and the extracellular matrix (ECM) produced by them have been recognized as key players in cancer biology and emerged as important targets for cancer treatment and drug discovery. Apart from their presence in stroma rich tumors, such as biliary, pancreatic and subtypes of hepatocellular cancer (HCC), both CAF and certain ECM components are also present in cancers without an overt intra-tumoral desmoplastic reaction. They support cancer development, growth, metastasis and resistance to chemo- or checkpoint inhibitor therapy by a multitude of mechanisms, including angiogenesis, ECM remodeling and active immunosuppression by secretion of tumor promoting and immune suppressive cytokines, chemokines and growth factors. CAF resemble activated hepatic stellate cells (HSC)\/myofibroblasts, expressing \u03b1-smooth muscle actin and especially fibroblast activation protein (FAP). Apart from FAP, CAF also upregulate other functional cell surface proteins like platelet-derived growth factor receptor \u03b2 (PDGFR\u03b2) or the insulin-like growth factor receptor II (IGFRII). Notably, if formulated with adequate size and zeta potential, injected nanoparticles home preferentially to the liver. Several nanoparticular formulations were tested successfully to deliver dugs to activated HSC\/myofibroblasts. Thus, surface modified nanocarriers with a cyclic peptide binding to the PDGFR\u03b2 or with mannose-6-phosphate binding to the IGFRII, effectively directed drug delivery to activated HSC\/CAF in vivo. Even unguided nanohydrogel particles and lipoplexes loaded with siRNA demonstrated a high in vivo uptake and functional siRNA delivery in activated HSC, indicating that liver CAF\/HSC are also addressed specifically by well-devised nanocarriers with optimized physicochemical properties. Therefore, CAF have become an attractive target for the development of stroma-based cancer therapies, especially in the liver.<\/jats:p>","DOI":"10.3390\/cells9092027","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T08:40:26Z","timestamp":1599122426000},"page":"2027","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-8003","authenticated-orcid":false,"given":"Leonard","family":"Kaps","sequence":"first","affiliation":[{"name":"Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, D-55131 Mainz, Germany"},{"name":"Deptartment of Medicine 1, University Medical Center, D-55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[{"name":"Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, D-55131 Mainz, Germany"},{"name":"Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","article-title":"Matrix as a modulator of hepatic fibrogenesis","volume":"21","author":"Schuppan","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"ref_4","first-page":"807","article-title":"Novel insights into the function and dynamics of extracellular matrix in liver fibrosis","volume":"308","author":"Karsdal","year":"2015","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_5","unstructured":"(2017). The good and the bad collagens of fibrosis\u2014Their role in signaling and organ function. Adv. Drug Deliv. Rev., 1, 43\u201356."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u03b1-fetoprotein concentrations (REACH-2): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sevic, I., Spinelli, F.M., Cantero, M.J., Reszegi, A., Kovalszky, I., Garc\u00eda, M.G., and Alaniz, L. (2019). The Role of the Tumor Microenvironment in the Development and Progression of Hepatocellular Carcinoma. Hepatocellular Carcinoma, Codon Publications.","DOI":"10.15586\/hepatocellularcarcinoma.2019.ch2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Feng, G., Hanley, K.L., Liang, Y., and Lin, X. (2020). Improving the Efficacy of Liver Cancer Immunotherapy: The Power of Combined Preclinical and Clinical Studies. Hepatology.","DOI":"10.1002\/hep.31479"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","article-title":"The role of collagen in cancer: From bench to bedside","volume":"17","author":"Xu","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2016.12.009","article-title":"The nature and biology of basement membranes","volume":"57","author":"Pozzi","year":"2017","journal-title":"Matrix Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bbagen.2014.02.018","article-title":"Non-collagenous ECM proteins in blood vessel morphogenesis and cancer","volume":"1840","author":"Kostourou","year":"2014","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/liv.12465","article-title":"Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: More complicated than ever","volume":"34","author":"Carloni","year":"2014","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.jhepr.2020.100115","article-title":"The liver matrisome, looking beyond collagens","volume":"2","author":"Arteel","year":"2020","journal-title":"Jhep Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Toffanin","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1038\/s41598-018-21937-2","article-title":"The immune contexture of hepatocellular carcinoma predicts clinical outcome","volume":"8","author":"Foerster","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds That Do Not Heal","volume":"315","author":"Flier","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a026781","article-title":"Tumor microenvironment and differential responses to therapy","volume":"7","author":"Hirata","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: A strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim. Biophys. Acta-Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s42003-018-0137-0","article-title":"Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation","volume":"1","author":"Kurashige","year":"2018","journal-title":"Commun. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Baglieri, J., Brenner, D., and Kisseleva, T. (2019). The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071723"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1600363113","article-title":"Tumor-associated fibroblasts predominantly come from local and not circulating precursors","volume":"113","author":"Arina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1573394711666151022203313","article-title":"Roles of Tumor Microenvironment in Hepatocelluar Carcinoma","volume":"11","author":"Seo","year":"2015","journal-title":"Curr. Cancer Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1309\/AJCP86PPBNGOHNNL","article-title":"Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative Resection","volume":"131","author":"Ju","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosisin Liver Cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4049098","article-title":"Osteopontin at the Crossroads of Inflammation and Tumor Progression","volume":"2017","author":"Castello","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41419-018-0391-6","article-title":"The role of osteopontin in the progression of solid organ tumour","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1440-1827.2002.01316.x","article-title":"Overexpression of osteopontin in hepatocellular carcinoma","volume":"52","author":"Gotoh","year":"2002","journal-title":"Pathol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncr.11487","article-title":"Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular cacinoma","volume":"98","author":"Pan","year":"2003","journal-title":"Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nm843","article-title":"Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning","volume":"9","author":"Ye","year":"2003","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.febslet.2006.05.032","article-title":"Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma","volume":"580","author":"Huang","year":"2006","journal-title":"Febs Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2006.00679.x","article-title":"Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma","volume":"101","author":"Kim","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00432-006-0119-3","article-title":"The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma","volume":"132","author":"Zhang","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.24703","article-title":"Identification of osteopontin as a novel marker for early hepatocellular carcinoma","volume":"55","author":"Shang","year":"2012","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","article-title":"HCC and angiogenesis: Possible targets and future directions","volume":"8","author":"Zhu","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/hepr.12356","article-title":"Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma","volume":"45","author":"Lin","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2008.07.065","article-title":"Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis","volume":"135","author":"Taura","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2006.051246","article-title":"Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: Role of HBV X protein","volume":"169","author":"Borque","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12013-014-9918-3","article-title":"Activated Human Hepatic Stellate Cells Promote Growth of Human Hepatocellular Carcinoma in a Subcutaneous Xenograft Nude Mouse Model","volume":"70","author":"Geng","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/jhep.2003.50068","article-title":"Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis","volume":"37","author":"Olaso","year":"2003","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2353\/ajpath.2010.100187","article-title":"Focal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growth","volume":"177","author":"Kang","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jcp.56.11.854","article-title":"Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma","volume":"56","author":"Sugimachi","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2004.01.027","article-title":"Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma","volume":"40","author":"Torimura","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Thompson, A.I., Conroy, K.P., and Henderson, N.C. (2015). Hepatic stellate cells: Central modulators of hepatic carcinogenesis. Bmc Gastroenterol., 15.","DOI":"10.1186\/s12876-015-0291-5"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.3748\/wjg.v22.i30.6841","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma","volume":"22","author":"Kubo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGF\u03b2 in Cancer","volume":"134","year":"2008","journal-title":"Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0038-1676121","article-title":"TGF-\u03b2 as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives","volume":"39","author":"Dituri","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming growth factor-\u03b2-induced cell plasticity in liver fibrosis and hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","article-title":"Role of epithelial to mesenchymal transition in hepatocellular carcinoma","volume":"65","author":"Giannelli","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.26526","article-title":"Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma","volume":"58","author":"Yoshida","year":"2013","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/JHC.S156701","article-title":"Role of Wnt\/\u03b2-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance","volume":"5","author":"Khalaf","year":"2018","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcell.2020.00055","article-title":"The Function of the HGF\/c-MET Axis in Hepatocellular Carcinoma","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0016-5085(98)70642-0","article-title":"Collagens in the liver extracellular matrix bind hepatocyte growth factor","volume":"114","author":"Schuppan","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1478-3231.2004.0926.x","article-title":"Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis","volume":"24","author":"Cramer","year":"2004","journal-title":"Liver Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","article-title":"Targeting the HGF\/c-MET pathway in hepatocellular carcinoma","volume":"19","author":"Goyal","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1038\/emm.2017.17","article-title":"Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy","volume":"49","author":"Kim","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"21260","DOI":"10.1038\/srep21260","article-title":"Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-00671-1","article-title":"TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice","volume":"7","author":"Thiele","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gong, Y., Scott, E., Lu, R., Xu, Y., Oh, W.K., and Yu, Q. (2013). TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077366"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12061","DOI":"10.18632\/oncotarget.3616","article-title":"TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1\/CXCR4 signaling in hepatocellular carcinoma","volume":"6","author":"Song","year":"2015","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ajpath.2013.03.018","article-title":"Failure of Fibrotic Liver Regeneration in Mice Is Linked to a Severe Fibrogenic Response Driven by Hepatic Progenitor Cell Activation","volume":"183","author":"Kuramitsu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1053\/j.gastro.2010.07.015","article-title":"Epithelial-to-mesenchymal transition in liver fibrosis: Dead or alive?","volume":"139","author":"Popov","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin \u03b1v\u03b26 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"ref_72","first-page":"3331","article-title":"Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans","volume":"10","author":"Omenetti","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/hep.23144","article-title":"Pharmacological inhibition of integrin \u03b1v\u03b23 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis","volume":"50","author":"Patsenker","year":"2009","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/ijc.25920","article-title":"Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice","volume":"29","author":"Zhao","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.18632\/oncotarget.6839","article-title":"Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.27822","article-title":"Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma","volume":"62","author":"Ji","year":"2015","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","article-title":"Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion","volume":"59","author":"Schildberg","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"30576","DOI":"10.18632\/oncotarget.15736","article-title":"Prognostic significance of tumor-associated macrophages in breast cancer: A meta-analysis of the literature","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jcmm.12787","article-title":"Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection","volume":"20","author":"Shu","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells","volume":"147","author":"Wan","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGF\u03b2","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.24384","article-title":"Hepatic stellate cells: Partners in crime for liver metastases?","volume":"54","author":"Kang","year":"2011","journal-title":"Hepatology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Fitzgerald, A.A., and Weiner, L.M. (2020). The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev.","DOI":"10.1007\/s10555-020-09909-3"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","article-title":"Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs","volume":"4","author":"Keane","year":"2014","journal-title":"Febs Open Bio"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.7150\/jca.25775","article-title":"The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes","volume":"9","author":"Zou","year":"2018","journal-title":"J. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/MCB.20.3.1089-1094.2000","article-title":"Targeted Disruption of Mouse Fibroblast Activation Protein","volume":"20","author":"Niedermeyer","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/icb.2016.116","article-title":"The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury","volume":"95","author":"Wang","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP Promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 Signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/cddis.2014.122","article-title":"Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0037-1613388","article-title":"Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis","volume":"89","author":"Aimes","year":"2003","journal-title":"Thromb. Haemost."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12253-017-0359-3","article-title":"Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer","volume":"25","author":"Gao","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","article-title":"MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypetrophic chondrocytes","volume":"93","author":"Vu","year":"1998","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000069863","article-title":"Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer","volume":"26","author":"Hofheinz","year":"2003","journal-title":"Oncol. Res. Treat."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: Orchestrating the composition of malignancy","volume":"30","author":"Gascard","year":"2016","journal-title":"Genes Dev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e00056","DOI":"10.14309\/ctg.0000000000000056","article-title":"A Phase 2 Study of Galunisertib (TGF\u03b21 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma","volume":"10","author":"Kelley","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1200\/JCO.2006.09.7097","article-title":"Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non-small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy","volume":"25","author":"Vansteenkiste","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival","volume":"25","author":"Carstens","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55013-0","article-title":"Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome","volume":"10","author":"Mezheyeuski","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s40425-019-0675-0","article-title":"Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma","volume":"7","author":"Wong","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Kilvaer, T.K., Khanehkenari, M.R., Hellevik, T., Al-Saad, S., Paulsen, E.E., Bremnes, R.M., Busund, L.T., Donnem, T., and Martinez, I.Z. (2015). Cancer associated fibroblasts in stage I-IIIA NSCLC: Prognostic impact and their correlations with tumor molecular markers. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134965"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780903382609","article-title":"Targeting the transforming growth factor-\u03b2 signaling pathway in human cancer","volume":"19","author":"Nagaraj","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41598-019-38678-5","article-title":"Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats","volume":"9","author":"Klein","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2017.11.029","article-title":"Pharmacokinetics of a sustained release formulation of PDGF\u03b2-receptor directed carrier proteins to target the fibrotic liver","volume":"269","author":"Teekamp","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.nano.2017.11.004","article-title":"Cell type-specific pharmacological kinase inhibition for cancer chemoprevention","volume":"14","author":"Deshmukh","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.01.022","article-title":"Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo","volume":"179","author":"Bansal","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon \u03b3 to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Bansal","year":"2012","journal-title":"Mol. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"Bansal","year":"2011","journal-title":"Hepatology"},{"key":"ref_113","first-page":"942","article-title":"Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"van Beuge, M.M., Prakash, J., Lacombe, M., Post, E., Reker-Smit, C., Beljaars, L., and Poelstra, K. (2013). Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056442"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor\u2013beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/acs.molpharmaceut.7b00709","article-title":"pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis","volume":"15","author":"Jia","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A\u2013coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jconrel.2020.02.049","article-title":"Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis","volume":"321","author":"Qiao","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2019.04.022","article-title":"An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis","volume":"303","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7150\/thno.21168","article-title":"Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development","volume":"8","author":"Sung","year":"2018","journal-title":"Theranostics"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.12.006","article-title":"SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles","volume":"248","author":"Leber","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/adhm.201500826","article-title":"In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles","volume":"4","author":"Kaps","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/hep.27936","article-title":"Specific hepatic delivery of procollagen \u03b11(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis","volume":"62","author":"Sehgal","year":"2015","journal-title":"Hepatology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbamem.2007.03.027","article-title":"A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats","volume":"1768","author":"Adrian","year":"2007","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s12035-016-9849-7","article-title":"Insulin-Like Growth Factor-II\/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.510290526","article-title":"Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells","volume":"29","author":"Beljaars","year":"1999","journal-title":"Hepatology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ijc.24914","article-title":"Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate\/insulin-like growth factor II receptor","volume":"126","author":"Prakash","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s11095-006-9025-2","article-title":"Mannose-6-phosphate\/insulin-like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells","volume":"23","author":"Greupink","year":"2006","journal-title":"Pharm. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11095-006-9175-2","article-title":"Targeting 15d-prostaglandin J2 to hepatic stellate cells: Two options evaluated","volume":"24","author":"Hagens","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2005.08.027","article-title":"Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems","volume":"4","author":"Adrian","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem. Pharm."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/anie.199713741","article-title":"Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the\u03b1v\u03b23 Integrin for a New Cancer Therapy","volume":"36","author":"Haubner","year":"1997","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: Direct antifibrotic agents and targeted therapies","volume":"69","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/nn204116u","article-title":"Cationic nanohydrogel particles as potential siRNA carriers for cellular delivery","volume":"6","author":"Nuhn","year":"2012","journal-title":"Acs Nano"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Kaps, L., Leber, N., Klefenz, A., Choteschovsky, N., Zentel, R., Nuhn, L., and Schuppan, D. (2020). In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by \u03b1-Mannosyl-Functionalized Cationic Nanohydrogel Particles. Cells, 9.","DOI":"10.3390\/cells9081905"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:07Z","timestamp":1760177167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":135,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cells9092027"],"URL":"https:\/\/doi.org\/10.3390\/cells9092027","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}